Know Cancer

or
forgot password

Epidemiological Study to Describe NSCLC Clinical Management Patterns in Central Eastern Europe and Russia. Lung-EPICLIN


N/A
18 Years
N/A
Not Enrolling
Both
Non Small Cell Lung Cancer

Thank you

Trial Information

Epidemiological Study to Describe NSCLC Clinical Management Patterns in Central Eastern Europe and Russia. Lung-EPICLIN


Inclusion Criteria:



- Confirmed NSCLC diagnosis (e.g.bronchoscopic biopsy or FNAB), all stages, men and
women, attending the responsible department of treating this type of patients for the
first time between January 1st, 2010 and March 31st, 2010

- For Patient Reported Outcome (PRO) sub-sample: ability to read and write since they
will be asked to participate in the PRO part of the study. Selection will not be
based on the disease stage of each patient, in order to avoid a selection bias.

- Tumour tissue samples (in paraffin-embedded blocks) suitable for EGFR mutation
testing available.

Exclusion Criteria:

- Mixed histology of small cell and non-small cell lung cancer.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Authority:

Russia: Ethics Committee

Study ID:

NIS-ORU-IRE-2009/1

NCT ID:

NCT01069835

Start Date:

February 2010

Completion Date:

March 2012

Related Keywords:

  • Non Small Cell Lung Cancer
  • Non small cell lung cancer
  • EGFR mutation
  • NSCLC
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location